期刊
APOPTOSIS
卷 21, 期 7, 页码 809-824出版社
SPRINGER
DOI: 10.1007/s10495-016-1246-1
关键词
Melatonin; Endoplasmic reticulum stress; Myocardial ischemia-reperfusion injury; Reperfusion injury salvage kinase pathway; Survivor activating factor enhancement pathway
资金
- National Natural Science Foundation of China [81470415, 81270170, 81200151, 81470411, 81570330, 81570231, 81570230, 81570232]
- International scientific and technological cooperation and exchange project of Shaanxi Province [2015KW-047]
- Science and technology co-ordinating innovative engineering project of Shaanxi Province [2013KTCL03-01]
- Subject Boosting Project of Xijing Hospital [XJZT14203, XJGX12C11, XJGX13LC15]
Recently, we demonstrated that melatonin reduced protein kinase RNA (PKR)-like ER kinase (PERK)-eukaryotic initiation factor 2 alpha (eIF2 alpha)-activating transcription factor-4 (ATF4)-mediated myocardial endoplasmic reticulum (ER) stress and apoptosis during myocardial ischemia-reperfusion (MI/R) injury. However, the underlying mechanisms are still not clear. Myocardial reperfusion injury salvage kinase (RISK) pathway as well as survivor activating factor enhancement (SAFE) pathway are two pivotal intrinsic pro-survival signaling cascades. In this study, we performed in vivo and in vitro experiment to investigate the ameliorative effect of melatonin on ER stress with a focus on RISK and SAFE pathways interaction. Male C57Bl/6 mice received melatonin (300 mu g/25 g/day, 3 days before MI/R surgery; 300 mu g/25 g, 25 min before the onset of ischemia) pre-treatment with or without the administration of LY294002 (a PI3K/Akt inhibitor), U0126 (an ERK1/2 inhibitor) or AG490 (a STAT3 pathway inhibitor). H9c2 cells were pre-treated with melatonin (100 mu M, 8 h) in the presence or absence of LY294002, U0126 or AG490. Compared with the I/R-injured group, melatonin effectively reduced myocardial apoptosis, oxidative stress and improved cardiac function. In addition, melatonin pre-treatment also increased the phosphorylation of Akt, GSK-3 beta, ERK1/2 and STAT3 and reduced PERK-eIF2 alpha-ATF4-mediated ER stress. However, these effects were blocked by LY294002, U0126 or AG490. Additionally, either LY294002 or U0126 treatment could inhibit STAT3 phosphorylation, whereas AG490 administration also reduced both Akt and ERK1/2 phosphorylation, indicating an interplay exists between RISK and SAFE pathways in melatonin's cardioprotective effect. In summary, our study demonstrates that RISK and SAFE pathways mediate the cardioprotective effect of melatonin against MI/R injury. Melatonin pre-treatment attenuates PERK-eIF2 alpha-ATF4-mediated ER stress and apoptosis during MI/R injury via RISK and SAFE pathways interaction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据